Free Access
Issue
Med Sci (Paris)
Volume 32, Number 8-9, Août–Septembre 2016
Page(s) 671 - 674
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20163208004
Published online 12 September 2016
  1. Lambert PH, Liu M, Siegrist C-A. Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med 2005 ; 11 : S54–S62. [PubMed] [Google Scholar]
  2. Bournazos S, DiLillo DJ, Ravetch JV. The role of Fc-FcγR interactions in IgG-mediated microbial neutralization. J Exp Med 2015 ; 212 : 1361–1369. [CrossRef] [PubMed] [Google Scholar]
  3. Lewis GK, Finzi A, DeVico AL, Pazgier M. Conformational masking and receptor-dependent unmasking of highly conserved env epitopes recognized by non-neutralizing antibodies that mediate potent ADCC against HIV-1. Viruses 2015 ; 7 : 5115–5132. [PubMed] [Google Scholar]
  4. Lambotte O, Ferrari G, Moog C, et al. Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS 2009 ; 23 : 897–906. [CrossRef] [PubMed] [Google Scholar]
  5. Corey L, Gilbert PB, Tomaras GD, et al. Immune correlates of vaccine protection against HIV-1 acquisition. Sci Transl Med 2015 ; 7 : 310rv7. [PubMed] [Google Scholar]
  6. Mouquet H. Antibody B cell responses in HIV-1 infection. Trends Immunol 2014 ; 35 : 549–561. [PubMed] [Google Scholar]
  7. Caskey M, Klein F, Lorenzi JCC, et al. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Nature 2015 ; 522 : 487–491. [CrossRef] [PubMed] [Google Scholar]
  8. Lynch RM, Boritz E, Coates EE, et al. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. Sci Transl Med 2015 ; 7 : 319ra206. [PubMed] [Google Scholar]
  9. Bournazos S, Klein F, Pietzsch J, et al. Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity. Cell 2014 ; 158 : 1243–1253. [PubMed] [Google Scholar]
  10. Halper-Stromberg A, Lu CL, Klein F, et al. Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell 2014 ; 158 : 989–999. [PubMed] [Google Scholar]
  11. Bruel T, Guivel-Benhassine F, Amraoui S, et al. Elimination of HIV-1-infected cells by broadly neutralizing antibodies. Nat Commun 2015 ; 7 : 10844. [Google Scholar]
  12. Malbec M, Porrot F, Rua R, et al. Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission. J Exp Med 2013 ; 210 : 2813–2821. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.